1 month ago
17
Sandoz Group AG plans to usage the Canadian marketplace arsenic a proceedings balloon for generic Ozempic, challenging Novo Nordisk A/S with a copycat mentation arsenic soon arsenic 2026.
Author of the article:
Bloomberg News
Paula Doenecke and Naomi Kresge
Published Dec 11, 2024 • 2 infinitesimal read
(Bloomberg) — Sandoz Group AG plans to usage the Canadian marketplace arsenic a proceedings balloon for generic Ozempic, challenging Novo Nordisk A/S with a copycat mentation arsenic soon arsenic 2026.
Article content
Article content
The Swiss drugmaker is betting that the existing procreation of GLP-1 weight-loss drugs volition enactment successful request — and that generics volition beryllium fashionable fixed the hefty terms tags of the branded products — adjacent arsenic Novo and US rival Eli Lilly & Co. propulsion guardant with much almighty contenders.
Advertisement 2
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe present to work the latest quality successful your metropolis and crossed Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily contented from Financial Times, the world's starring planetary concern publication.
- Unlimited online entree to work articles from Financial Post, National Post and 15 quality sites crossed Canada with 1 account.
- National Post ePaper, an physics replica of the people variation to presumption connected immoderate device, stock and remark on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe present to work the latest quality successful your metropolis and crossed Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily contented from Financial Times, the world's starring planetary concern publication.
- Unlimited online entree to work articles from Financial Post, National Post and 15 quality sites crossed Canada with 1 account.
- National Post ePaper, an physics replica of the people variation to presumption connected immoderate device, stock and remark on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an relationship oregon motion successful to proceed with your speechmaking experience.
- Access articles from crossed Canada with 1 account.
- Share your thoughts and articulation the speech successful the comments.
- Enjoy further articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an relationship oregon motion successful to proceed with your speechmaking experience.
- Access articles from crossed Canada with 1 account
- Share your thoughts and articulation the speech successful the comments
- Enjoy further articles per month
- Get email updates from your favourite authors
Sign In oregon Create an Account
or
Article content
Sandoz is investing successful accumulation to beryllium 1 of the archetypal sellers of a reliable generic mentation of semaglutide, the main constituent successful Ozempic, for diabetes successful Canada, 1 of the fewer countries wherever it tin beryllium sold, according to Chief Executive Officer Richard Saynor.
“Everyone’s excited astir second-generation GLP-1s, but existent drugs are effective,” the CEO said Tuesday successful an interview. “I deliberation these drugs are present to enactment for a agelong time.”
The existing medicines tin spur a value nonaccomplishment of 10% to 15% — capable for astir patients — and person shown their powerfulness by denting obesity successful the US, according to Saynor.
One successful Three
Novo’s Wegovy, the mentation of the cause sold for value nonaccomplishment alternatively than diabetes, became disposable for patients successful Canada this year. A generic wouldn’t beryllium introduced for respective years aft the Ozempic copy, but some medicines stock the aforesaid progressive ingredient.
In Canada, astir 1 successful 3 adults reported being obese successful 2022. The state is the second-largest marketplace for semaglutide, according to Saynor.
Already Wegovy and others similar Lilly’s Zepbound are among the astir fashionable medicines ever, but their terms tag is keeping them retired of scope for some.
“If the terms comes down from, I don’t know, a fewer 100 oregon a 1000 dollars a period to a fewer tens of dollars a month, the diligent population’s size is insane,” Saynor said.
Sandoz’s precedence is to guarantee its transcript of semaglutide is harmless for patients, helium said.
Wegovy’s patent connected semaglutide expires successful 2032 successful the US and 2031 successful Europe, according to Novo. The patent expires successful 2026 successful China, wherever a fig of section drugmakers are already queuing up to merchantability generic copies.
Article content
.jpg)
English (US) ·